Norris Medicines Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 0.74 | 1.52 | 0.65 |
| Operating Expense | 0.89 | 1 | 0.69 |
| Net Profit | -0.37 | 0.17 | -0.27 |
| Net Profit Margin | -50 | 11.18 | -41.54 |
| Earning Per Share | -0.37 | 0.17 | -0.27 |
| EBIDTA | -0.16 | 0.42 | -0.04 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 0.74 |
| Operating Expense | 0.89 |
| Net Profit | -0.37 |
| Net Profit Margin | -50.00 |
| Earning Per Share | -0.37 |
| EBIDTA | -0.16 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 8.36 | 9.44 | 12.25 |
| Operating Expenses Annual | 7.44 | 9.51 | 14.00 |
| Operating Profit Annual | 0.94 | -0.05 | -1.69 |
| Interest Annual | 1.50 | 1.48 | 1.63 |
| Depreciation | 0.63 | 0.66 | 0.67 |
| Net Profit Annual | -1.75 | -3.26 | -4.96 |
| Tax Annual | 0.56 | 1.08 | 0.97 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 8.36 |
| Operating Expenses Annual | 7.44 |
| Operating Profit Annual | 0.94 |
| Interest Annual | 1.50 |
| Depreciation | 0.63 |
| Net Profit Annual | -1.75 |
| Tax Annual | 0.56 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.02 | 0.02 | 0.06 |
| Cash Flow from Operations | 1.20 | -1.01 | 1.11 |
| Cash Flow from Investing | -0.02 | -0.09 | -0.06 |
| Cash Flow from Financing | -1.18 | 1.10 | -1.09 |
| Cash Flow at the End | 0.02 | 0.02 | 0.02 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.02 |
| Cash Flow from Operations | 1.20 |
| Cash Flow from Investing | -0.02 |
| Cash Flow from Financing | -1.18 |
| Cash Flow at the End | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | 11.24 | -0.53 | -13.88 |
| PBIT Margin (%) | 3.71 | -7.52 | -19.35 |
| PBT Margin (%) | 1.20 | -2.54 | -7.51 |
| Net PROFIT Margin (%) | -20.93 | -34.53 | -40.49 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -18.00 | -35.22 | -42.11 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.86 | 1.02 | 1.04 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | 11.24 |
| PBIT Margin (%) | 3.71 |
| PBT Margin (%) | 1.20 |
| Net PROFIT Margin (%) | -20.93 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -18.00 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.86 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 6.47 | 7.07 | 7.67 |
| Total Current Assets Annual | 4.92 | 4.27 | 8.23 |
| Non Current Assets Annual | 8.77 | 9.92 | 11.55 |
| Total Shareholders Funds Annual | -12.44 | -10.69 | -7.43 |
| Total Assets Annual | 13.69 | 14.19 | 19.79 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 6.47 |
| Total Current Assets Annual | 4.92 |
| Non Current Assets Annual | 8.77 |
| Total Shareholders Funds Annual | -12.44 |
| Total Assets Annual | 13.69 |
No Data Availabe
